Pepgen Inc (PEPG)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
PepGen Inc. Makes Waves with $80.1 Million Underwritten Offering of Common Stock
PepGen*s PGN-EDO51: Unleashing Hope for Duchenne Muscular Dystrophy with Exon Skipping
PepGen Advances to Clinical Trials as it Tests PGN-EDODM1 Against Myotonic Dystrophy Type 1
PEPG Sets the Stage on Fire with Record-Breaking Performance in Q3 of 2023!
Business outlays have been building up at the PEPG in the second quarter of 2023 earnings season
A Road to Recovery with Promising Q1 Results, But Still Trails Competitors
The company reported operating shortfall of $-19.554 million, in the most recent fiscal period